Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
2018
Mepolizumab can reduce exacerbation rates in those with frequently exacerbating, severe COPD and raised blood eosinophils; this represents a further advance in precision medicine for COPD and targeted therapies http://ow.ly/uklu30m4YcU
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
18
References
5
Citations
NaN
KQI